Literature DB >> 1475084

Fluorescein-angiographic patterns in patients with central serous chorioretinopathy at the initial visit.

K Yamada1, S Hayasaka, T Setogawa.   

Abstract

We reviewed the clinical records, color photographs and fluorescein angiograms of 106 eyes of 53 patients (44 men and 9 women) with central serous chorioretinopathy who had been followed up for 1 year or more. Their ages ranged from 20 to 59 years. One eye in each patient was involved at the initial visit. According to fluorescein-angiographic findings, the lesions were divided into smokestack pattern (13 eyes), ink blot appearance (33 eyes) and minimally enlarging spot (7 eyes). Most patients complained of central scotoma, and most patients had moderately decreased visual acuities at the initial visit, which improved after recovery. In particular, all 7 eyes with a minimally enlarging spot had a visual acuity of 0.8 or more at the initial visit; of these 6 eyes had 1.0 or more several weeks later. On fluorescein angiography, 49 eyes demonstrated 1 leaking spot and 4 eyes showed 2 spots. Of 57 leaking spots, 10 were observed in the foveola, 31 were noted in the fovea and 16 were found in the para- or perifovea. Of 13 smokestack patterns, 5 were found in the inferonasal area. The ink blot appearance and minimally enlarging spots were frequently found in the superonasal and superotemporal areas.

Entities:  

Mesh:

Year:  1992        PMID: 1475084     DOI: 10.1159/000310315

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  7 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

3.  Factors influencing the visual acuity of chronic central serous chorioretinopathy.

Authors:  Yun Young Kim; Christina J Flaxel
Journal:  Korean J Ophthalmol       Date:  2011-03-11

Review 4.  The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy.

Authors:  Stefano Da Pozzo; Pierluigi Iacono; Alessandro Arrigo; Maurizio Battaglia Parodi
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-29

5.  Chinese medicine, Gui Lu Er Xian Jiao - related serous retinal detachment 2nd to circumscribed choroidal hemangioma a case report.

Authors:  Hsin Hui Huang; Shiuh-Liang Hsu; Shwu-Jiuan Sheu
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-10

Review 6.  Central serous chorioretinopathy: Current update on pathophysiology and multimodal imaging.

Authors:  George Joseph Manayath; Ratnesh Ranjan; Vanee Sheth Shah; Smita S Karandikar; Veerappan R Saravanan; Venkatapathy Narendran
Journal:  Oman J Ophthalmol       Date:  2018 May-Aug

7.  Combined Argon Laser and Low Dose Acetylsalicylic acid in Treatment of Acute Central Serous Chorioretinopathy.

Authors:  Alahmady Hamad Alsmman; Engy Mohamed Mostafa; Amr Mounir
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.